Plastlabor
Innovative diagnostic kits for detecting drug-resistant bacteria and tuberculosis, enhancing clinical accuracy and patient outcomes.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Acquisition | |
| Total Funding | 000k | ||
PlastLabor specializes in the development and distribution of diagnostic kits designed to detect drug-resistant bacteria and Mycobacterium tuberculosis. Operating within the healthcare and medical diagnostics market, PlastLabor serves hospitals, clinical laboratories, and research institutions. The company’s business model revolves around the sale of its proprietary diagnostic kits, which are used to identify resistance to critical antibiotics and tuberculosis treatment drugs. Revenue is generated through direct sales and long-term supply agreements with healthcare providers. PlastLabor’s products are crucial in the fight against antibiotic resistance, providing healthcare professionals with reliable tools for early detection and effective treatment planning.
Keywords: diagnostic kits, drug resistance, Mycobacterium tuberculosis, healthcare, clinical laboratories, hospitals, antibiotic resistance, tuberculosis detection, medical diagnostics, proprietary technology.